Economic Benefit of Anti-PLA2R Antibody Testing in the Diagnosis of Membranous Nephropathy: A Single-Center Cost Analysis

Background: This study aimed to evaluate the financial impact of using anti-phospholipase A2 receptor antibody testing instead of kidney biopsy for diagnosing membranous nephropathy. Methods: A retrospective cross-sectional study was conducted at Gazi University Faculty of Medicine Hospital bet...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Asil Demirezen, Nuri Alperen Malkoç, Ömer Faruk Akçay, Saliha Yıldırım, Emre Yaşar, Sena Türkmen, Özlem Gülbahar, Betül Öğüt, İpek Işık Gönül, Galip Güz, Ülver Derici, Yasemin Erten, Kadriye Altok, Özant Helvacı
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Turkish Society of Nephrology 2025-10-01
סדרה:	Turkish Journal of Nephrology
נושאים:	Cost analysis diagnosis membranous nephropathy nephrotic syndrome phospholipase A2 receptor
גישה מקוונת:	https://turkjnephrol.org/index.php/pub/article/view/1670
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!